Archive: startup

Premium

Startup Insider: What It’s Like in the SeedInvest Bullpen

By Early Investing on January 6, 2020

In Part 1 of our interview with SeedInvest Principal Alex Tynion, we learn how SeedInvest vets startups, how the team handles valuations and more.
Premium

Startup Insider: Cityzenith Builds an All-Star Team

By Early Investing on December 16, 2019

In Part 2 of our Startup Insider interview with Cityzenith, we learn that the company has some exciting projects in its pipeline.

How to Ignite Capital Growth in 2020 (Not Through IPOs)

By Andy Gordon on December 11, 2019

Direct listings minimize risk for startup investors and help them cash out faster. But they also come with a downside. Fortunately, that may change in 2020.

Mailbag: To Short or Not to Short

By Early Investing on December 6, 2019

In this week’s Mailbag, the Early Investing team explains whether it recommends shorting U.S. stocks and what happens to your shares when a startup gets bought out.

Mailbag: Commit or Go Home

By Early Investing on November 22, 2019

In this week’s Mailbag, the Early Investing team addresses pot stocks and startup investing commitments.
Premium
In Part 3 of our Startup Insider interview with NowRx, we take a deep dive into the founders’ strategy.

Startup Insider: How NowRx Works With Google Home

By Early Investing on November 7, 2019

In Part 2 of our interview with NowRx, we go behind the scenes to see how the company tracks orders, maps out delivery routes and more.
Premium

Recommendation: Reinvest in NowRx

By Early Investing on November 4, 2019

Today’s Startup Insider video features the founders of NowRx, a startup that’s disrupting the brick-and-mortar pharmacy industry. In Part 1 of this interview, they discuss what they do, what inspired them to start the company and more.

Mailbag: Defining Reasonable Revenue Growth

By Early Investing on October 27, 2019

In this week’s Mailbag, the Early Investing team explains reasonable revenue growth numbers and underperforming IPOs.
Premium

Don’t Invest Based on Sector

By Adam Sharp on October 24, 2019

Here’s why you should avoid deals in “hot” industries that don’t have any real traction.
Premium
Aavrani is a startup breaking into the rapidly growing natural skin care market. It’s got happy customers, experienced founders and plenty more to convince Andy Gordon it’s a sound investment.
Premium

Startup Investing During Shaky Financial Times

By Adam Sharp on October 8, 2019

We’re headed for some rocky financial times. Many legacy companies will fall. But that means there’s a great opportunity for startups to take over.
Premium
Imagine a Berkshire Hathaway that invests only in companies developing products that are good for the body. Orthogonal Thinker founder David Nikzad is doing just that. And it’s a very personal mission.
Premium

20/20 GeneSystems Is on the Verge of a Big Upswing

By Andy Gordon on July 29, 2019

20/20 GeneSystems is expanding its marketing efforts and is on the verge of major revenue growth.
Premium

Invest in a Bootstrapping Startup With Good Taste

By Adam Sharp on June 10, 2019

Taste is a bootstrapping startup that offers TV and movie recommendations using sophisticated algorithms and machine learning. Here’s why we like it.
Premium
Our friends at KingsCrowd warn against investing in this niche travel startup.